Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		9 Months Ended
		Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities
Net loss		$ (300,663)	$ (462,476)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		12,993	10,697
Amortization of deferred contract acquisition costs		37,967	19,904
Net amortization of premium on marketable securities		501	1,391
Stock-based compensation expense		270,797	438,551
Charitable donation of Class A common stock		5,499	0
Amortization of operating lease right-of-use assets		8,555	6,013
Provision for deferred income taxes		1,171	(357)
Abandonment and impairment charges		2,881	0
Other non-cash (credits) charges, net	[1]	(1,714)	1,599
Changes in operating assets and liabilities:
Accounts receivable		(33,449)	(27,028)
Contract assets		(27,735)	(29,994)
Deferred contract acquisition costs		(69,657)	(80,720)
Prepaid expenses and other assets		(27,361)	(2,295)
Accounts payable		2,414	17,549
Accrued expense and other liabilities		(13,785)	17,756
Accrued compensation and employee benefits		(26,096)	(822)
Operating lease liabilities, net		(488)	(5,261)
Deferred revenue		54,232	46,544
Net cash used in operating activities		(103,938)	(48,949)
Cash flows from investing activities
Purchases of marketable securities		(204,311)	(161,214)
Sales of marketable securities		0	89,383
Maturities of marketable securities		93,298	58,109
Purchases of property and equipment		(21,614)	(5,719)
Capitalization of software development costs		0	(2,950)
Payments related to business acquisitions, net of cash acquired		(29,542)	(5,498)
Other investing, net		(507)	(1,231)
Net cash used in investing activities		(162,676)	(29,120)
Cash flows from financing activities
Proceeds from exercise of stock options		7,605	9,687
Payments of tax withholdings on net settlement of equity awards		(53,300)	(10,300)
Net (payments) receipts of tax withholdings on sell-to-cover equity award transactions		(10,132)	20,418
Proceeds from employee stock purchase plan contributions		13,525	13,766
Repurchase of unvested early exercised stock options		(1,493)	0
Proceeds from initial public offering, net of underwriting discounts and commissions		0	692,369
Payments of initial public offering costs		0	(3,734)
Proceeds from issuance of convertible preferred stock		0	750,000
Payments of issuance costs for convertible preferred stock		0	(164)
Net cash (used in) provided by financing activities		(43,795)	1,472,042
Effect of exchange rate changes		(7,162)	11,254
Net (decrease) increase in cash, cash equivalents and restricted cash		(317,571)	1,405,227
Cash, cash equivalents, and restricted cash - beginning of period		1,768,723	371,190
Cash, cash equivalents, and restricted cash - end of period		1,451,152	1,776,417
Supplemental disclosure of cash flow information
Cash paid for interest		720	512
Cash paid for income taxes		19,060	6,680
Supplemental disclosure of non-cash investing and financing activities
Stock-based compensation capitalized for software development		0	4,487
Value of shares issued in payment of business acquisitions		2,965	30,467
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options		1,355	2,723
Payable for marketable securities purchase		2,894	0
Deferred payments related to business acquisitions		11,433	0
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid		$ 2,517	$ 445

[1] (1) Prior period amounts have been combined to conform to current presentation